DEFB129 and neoplasm: One of the first modifications to ID8 cells was the stable expression of beta-defensin, Defb29, and Vegf-A yielding ID8-Defb29/Veg-A cells that had increased pro-tumor DC recruitment, neovasculature, and a more aggressive phenotype with reduced survival compared with parental ID8 cells [148].